메뉴 건너뛰기




Volumn 349, Issue , 2014, Pages

Early identification and management of chronic kidney disease in adults: Summary of updated NICE guidance

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CREATININE; SERUM ALBUMIN;

EID: 84904619666     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g4507     Document Type: Article
Times cited : (42)

References (13)
  • 1
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
    • (2002) Am J Kidney Dis , vol.39
  • 2
    • 84897452221 scopus 로고    scopus 로고
    • Pro: Thresholds to define chronic kidney disease should not be age-dependent
    • Conte G, Minutolo R, De Nicola L. Pro: thresholds to define chronic kidney disease should not be age-dependent. Nephrol Dial Transplant 2014;29:770-4.
    • (2014) Nephrol Dial Transplant , vol.29 , pp. 770-774
    • Conte, G.1    Minutolo, R.2    De Nicola, L.3
  • 3
    • 84897461810 scopus 로고    scopus 로고
    • Con: Thresholds to define chronic kidney disease should not be age dependent
    • Glassock R. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant 2014;29:774-9.
    • (2014) Nephrol Dial Transplant , vol.29 , pp. 774-779
    • Glassock, R.1
  • 5
    • 84874644599 scopus 로고    scopus 로고
    • KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
    • Kidney Disease: Improving Global Outcomes (KDIGO) Work Group
    • Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-150.
    • (2013) Kidney Int Suppl , vol.3 , pp. 1-150
  • 7
    • 79955009821 scopus 로고    scopus 로고
    • Detection of chronic kidney disease with creatinine, cystatin C, and urinary albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality
    • Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urinary albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545-52.
    • (2011) JAMA , vol.305 , pp. 1545-1552
    • Peralta, C.A.1    Shlipak, M.G.2    Judd, S.3    Cushman, M.4    McClellan, W.5    Zakai, N.A.6
  • 8
    • 84875014115 scopus 로고    scopus 로고
    • Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes
    • Waheed S, Matsushita K, Astor BC, Hoogeveen RC, Ballantyne C, Coresh J. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol 2013;8:434-42.
    • (2013) Clin J Am Soc Nephrol , vol.8 , pp. 434-442
    • Waheed, S.1    Matsushita, K.2    Astor, B.C.3    Hoogeveen, R.C.4    Ballantyne, C.5    Coresh, J.6
  • 9
    • 84860786143 scopus 로고    scopus 로고
    • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate
    • Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51.
    • (2012) JAMA , vol.307 , pp. 1941-1951
    • Matsushita, K.1    Mahmoodi, B.K.2    Woodward, M.3    Emberson, J.R.4    Jafar, T.H.5    Jee, S.H.6
  • 10
    • 84863984918 scopus 로고    scopus 로고
    • Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR
    • for the Alberta Kidney Disease Network
    • Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR, for the Alberta Kidney Disease Network. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR. Am J Kidney Dis 2012;60:241-9.
    • (2012) Am J Kidney Dis , vol.60 , pp. 241-249
    • Matsushita, K.1    Tonelli, M.2    Lloyd, A.3    Levey, A.S.4    Coresh, J.5    Hemmelgarn, B.R.6
  • 11
    • 84902826499 scopus 로고    scopus 로고
    • Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
    • published online 3 June
    • Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; published online 3 June.
    • (2014) JAMA
    • Coresh, J.1    Turin, T.C.2    Matsushita, K.3    Sang, Y.4    Ballew, S.H.5    Appel, L.J.6
  • 13
    • 84862777509 scopus 로고    scopus 로고
    • Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis
    • O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis 2012;59:513-22.
    • (2012) Am J Kidney Dis , vol.59 , pp. 513-522
    • O'Hare, A.M.1    Batten, A.2    Burrows, N.R.3    Pavkov, M.E.4    Taylor, L.5    Gupta, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.